PALBOCICLIB IN COMBINATION WITH HORMONE THERAPY FOR LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER: NEW HIGHLY EFFECTIVE STRATEGY OF DRUG TREATMENT
The review considers a new oral targeted drug palbociclib and its place in treatment of luminal (estrogen receptor-positive) HER2– metastatic breast cancer. The results of randomized clinical trials have shown that inclusion of palbociclib in various hormone therapy regimens for treatment of HER2– m...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2017-09-01
|
| Series: | Opuholi Ženskoj Reproduktivnoj Sistemy |
| Subjects: | |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/549 |